Transfusion acquired hepatitis C - The Danish lookback experience;Transfusionsoverfort hepatitis C. Den danske " lookback "-undersogelse

Ugeskrift for Laeger

Volumn 162, Issue 18, 2000, Pages 2554-2557

  Christensen, Peer Brehm ^a   Grønbæk, Karin E ^b   Krarup, Henrik Bygum ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ARTICLE; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; BLOODBORNE BACTERIUM; DENMARK; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HETEROZYGOTE; HUMAN; IMMUNOLOGY; MALE; RETROSPECTIVE STUDY; STATISTICS;

BLOOD DONORS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; CARRIER STATE; DENMARK; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; RETROSPECTIVE STUDIES; RNA, VIRAL;

EID: 5844256787     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kolho E, Naukkarinen R, Krusius T. Transmission of HCV infection by RIBA indeterminate and positive blood units. Transfus Med 1992: 2: 243-8.
2. Skaug K, Li H, Jonassen TO, Larsen J, Figenschau KJ. Hepatitis C virus (HCV) RNA among anti-HCV-positive blood donors and their recipients. Vox Sang 1993; 64: 215-9.
3. Vrielink H, Van der Poel CL, Reesink HW, Zaaijer HL, Scholten E, Kremer LC et al. Look-back study of infectivity of anti-HCV ELISA-positive blood components. Lancet 1995; 345: 95-6.
4. Ayob Y, Davidson JI, Baxter A, Jordan A, Yap PL, Gillon J. Risk of hepatitis C in patients who received blood from donors subsequently shown to be carriers of hepatitis C virus. Transfus Med 1994; 4: 269-72.
5. Koerner K, Da Silva Cardoso M Dengler T. Kerowgan M, Kubanek B. Look back on hepatitis C-virus infections of HCV-RIBA-2-positive blood donors and their respective recipients. Vox Sang 1995; 69: 78-9.
6. Norda R, Duberg AS, Sonnerborg A, Olcen P. Transmission of hepatitis C virus by transfusion in Orebro County, Sweden, 1990-1992. Scand J Infect Dis 1995; 27: 449-52.
7. Foberg U, Ekermo B, Widell A, Mathiesen U, Fryden A. Hepatitis C virus transmission, 1988-1991, via blood components from donors subsequently found to be anti-HCV-positive. Scand J Infect Dis 1996; 28: 21-6.
8. Morris K, Bharucha C. Completed hepatitis C lookback in Northern Ireland. Transfus Med 1997; 7: 269-5.
9. Smith BC, Chapman CE, Burt AD, Toms GL, Bassendine MF. Outcome of post-transfusion hepatitis C: disease severity in blood-component recipients and their implicated donors. QJM 1997; 90: 587-92.
10. Riisom K, Møller A. Hepatitis C viral (HCV) status in recipients transfused with blood from anti-HCV seropositive donors. Ugeskr Læger 1998; 160: 1637-9.
11. Krarup HB, Drewes AM, Madsen PH. A quantitative HCV-PCR test for routine diagnostics. Scand J Clin Lab Invest 1998; 58: 415-22.
12. Dean AG, Dean JA, Columbier D et al. Epi Info Version 6.04: a wordprocessing, database, and statistics program for epidemiology on microcomputers. Atlanta, Georgia: Center for Disease Control and Prevention, 1997.
13. Heintges T, Wands JR. Hepatitis C virus: epidemiology and transmission. Hepatology 1997; 26: 521-6.
14. Conry CC, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 1691-6.
15. Kolho EK, Krusius T. Risk factors for hepatitis C virus antibody positivity in blood donors in a low-risk country. Vox Sang 1992; 63: 192-7.
16. Gronbaek KE, Jensen OJ, Krarup HB, Dietrichson O. Biochemical, virological and histopathological changes in Danish blood donors with antibodies to hepatitis C virus. Dan Med Bull 1996; 43: 186-8.
17. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349: 825-32.
18. Reichard O, Norkrans G, Fryden A, Braconier JH, Sonnerborg A, Weiland O. Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. Lancet 1998; 351: 83-7.